- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Genetic Technologies Ltd (GTG)
Genetic Technologies Ltd stock price live, this page displays ASX GTG stock exchange data. View the GTG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Genetic Technologies Ltd real time stock price chart below.
What Is the Genetic Technologies Ltd Stock Price Today?
The Genetic Technologies Ltd stock price today is 0.0490.
What Is the Stock Symbol for Genetic Technologies Ltd?
The stock symbol for Genetic Technologies Ltd is ""GTG.""
What Stock Exchange Does Genetic Technologies Ltd Trade On?
Genetic Technologies Ltd is listed and trades on the Sydney stock exchange.
Is Genetic Technologies Ltd a Good Stock to Buy?
Determining whether Genetic Technologies Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GTG quote. (ISIN: AU000000GTG7)
What Is the Genetic Technologies Ltd Stock Price Today?
The Genetic Technologies Ltd stock price today is 0.0490.
What Is the Stock Symbol for Genetic Technologies Ltd?
The stock symbol for Genetic Technologies Ltd is ""GTG.""
What Stock Exchange Does Genetic Technologies Ltd Trade On?
Genetic Technologies Ltd is listed and trades on the Sydney stock exchange.
Is Genetic Technologies Ltd a Good Stock to Buy?
Determining whether Genetic Technologies Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GTG quote. (ISIN: AU000000GTG7)
0.0490
0.0000(0.00%)
Closed·
Fair Value
An estimate of a Genetic Technologies Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0185
0.0490
52 wk Range
0.0130
0.0490
GTG Scorecard
Full Analysis
Quickly burning through cash
Trading near 52-week High
1/2
Fair Value
An estimate of a Genetic Technologies Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.01850.0490
52 wk Range
0.01300.0490
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
GTG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Genetic Technologies Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with low price volatility
- Genetic Technologies announces $2M ADS offering
- Investing.com
- Appendix 4C & Quarterly Business Update “ March 2024
- Investing.com
- Appendix 4C & Quarterly Business Update “ March 2024
- Investing.com
- Genetic Technologies announces $2M ADS offering
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Genetic Technologies Ltd Company Profile
Genetic Technologies Limited, a molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people’s health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company operates through EasyDNA, AffinityDNA, and GeneType/Corporate segments. It offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. The company also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, it offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include colorectal cancer, ovarian cancer, prostate cancer, coronary artery, type 2 diabetes, pancreatic cancer, melanoma, and atrial fibrillation. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. It has research and collaboration agreements with the University of Melbourne for the development and commercialization of a novel colorectal cancer risk assessment test; Memorial Sloan Kettering Cancer Center of New York and University of Cambridge, that assess the conflict among BRCA mutation carriers considering preventive surgery; and research collaboration with Harvard University, Ohio State University, and Washington University. The company was incorporated in 1987 and is headquartered in Maroochydore, Australia.
Compare GTG to Peers and Sector
Metrics to compare | GTG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGTGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.3x | −1.6x | −0.5x | |
PEG Ratio | −0.18 | −0.01 | 0.00 | |
Price/Book | 28.5x | 1.3x | 2.6x | |
Price / LTM Sales | 5.4x | 3.6x | 3.3x | |
Upside (Analyst Target) | - | 110.8% | 42.8% | |
Fair Value Upside | Unlock | 17.0% | 6.5% | Unlock |
Earnings
Latest Release
Sep 30, 2024
EPS / Forecast
-0.04 / --
Revenue / Forecast
4.80M / --
FAQ
What Stock Exchange Does Genetic Technologies Ltd Trade On?
Genetic Technologies Ltd is listed and trades on the Frankfurt Stock Exchange stock exchange.
What Is the Stock Symbol for Genetic Technologies Ltd?
The stock symbol for Genetic Technologies Ltd is "GTG."
What Is the Genetic Technologies Ltd Market Cap?
As of today, Genetic Technologies Ltd market cap is 29.18M.
What Is Genetic Technologies Ltd's Earnings Per Share (TTM)?
The Genetic Technologies Ltd EPS (TTM) is -0.09.
From a Technical Analysis Perspective, Is GTG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Genetic Technologies Ltd Stock Split?
Genetic Technologies Ltd has split 2 times.
How Many Employees Does Genetic Technologies Ltd Have?
Genetic Technologies Ltd has 55 employees.
What is the current trading status of Genetic Technologies Ltd (GTG)?
As of 06 Aug 2025, Genetic Technologies Ltd (GTG) is trading at a price of 0.05, with a previous close of 0.05. The stock has fluctuated within a day range of 0.02 to 0.05, while its 52-week range spans from 0.01 to 0.05.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.